HAIKOU CITY, China, May 7 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) , which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release first quarter 2009 financial results on Friday, May 15, 2009, before the market opens.
The Company will hold a conference call at 8:00 am ET on May 15, 2009 to discuss fiscal first quarter 2009 results. Listeners may access the call by dialing 1-800-901-5241 or 1-617-786-2963 for international callers, access code: 38020856. A webcast will also be available through CPHI’s website at http://www.chinapharmaholdings.com . A replay of the call will be available through May 22, 2009. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 72616938.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. ThChina Pharma Holdings, Inc. to Report First Quarter 2009 Financial Results on May 15, 2009 Company’s cost-effective, high margin business model is driven by market demand and supported by a scalable GMP-certified manufacturing infrastructure. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medicine & Bio-pharmaceutical Co., Ltd (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
CONTACT: China Pharma Holdings, Inc. at +86-898-6681-1730 or
hps@chinapharmaholdings.com; Or Christine Duan, ICR, Inc. at
+1-203-682-8200
Web site: http://www.chinapharmaholdings.com/
